Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VNSYX | 23.18 | 0.20 | +0.87% |
| Natixis Vaughan Nelson Select Y | |||
| ALGCX | 17.43 | 0.10 | +0.58% |
| Alger International Opportunities C | |||
| JGRUX | 86.15 | 0.37 | +0.43% |
| JPMorgan US Value R4 | |||
| HLPPX | 9.95 | 0.04 | +0.40% |
| LDR Real Estate Value Opportunity P | |||
| GROYX | 60.96 | 0.01 | +0.02% |
| Victory Pioneer Select Mid Cap Growth Y | |||
A.I.dvisor indicates that over the last year, NWPHF has been loosely correlated with INSM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NWPHF jumps, then INSM could also see price increases.
| Ticker / NAME | Correlation To NWPHF | 1D Price Change % | ||
|---|---|---|---|---|
| NWPHF | 100% | N/A | ||
| INSM - NWPHF | 49% Loosely correlated | -5.11% | ||
| SGMT - NWPHF | 35% Loosely correlated | -9.54% | ||
| MMIRF - NWPHF | 30% Poorly correlated | N/A | ||
| NURPF - NWPHF | 5% Poorly correlated | N/A | ||
| PRVCF - NWPHF | 4% Poorly correlated | -9.16% | ||
More | ||||